Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-01-25 @ 8:04 AM
Study NCT ID:
NCT00030667
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
2002-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Childhood Desmoplastic Small Round Cell Tumor | View |
| None | Childhood Synovial Sarcoma | View |
| None | Gastrointestinal Stromal Tumor | View |
| None | Lung Metastases | View |
| None | Recurrent Childhood Soft Tissue Sarcoma | View |
| None | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | View |
| None | Recurrent Neuroblastoma | View |
| None | Recurrent Osteosarcoma | View |
Keywords: